日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Altered liver sinusoidal endothelial cells in MASLD and their evolution following lanifibranor treatment

MASLD中肝窦内皮细胞的改变及其在拉尼菲布诺治疗后的演变

期刊:Jhep Reports
影响因子:7.5
doi:10.1016/j.jhepr.2025.101366
Rautou, Pierre-Emmanuel; Chotkoe, Shivani; Biquard, Louise; Wettstein, Guillaume; van der Graaff, Denise; Liu, Yao; De Man, Joris; Casteleyn, Christophe; Thys, Sofie; De Vos, Winnok H; Bedossa, Pierre; Cooreman, Michael P; Baudin, Martine; Abitbol, Jean-Louis; Huot-Marchand, Philippe; Dzen, Lucile; Albuquerque, Miguel; Broqua, Pierre; Junien, Jean-Louis; Vonghia, Luisa; Abdelmalek, Manal F; Kwanten, Wilhelmus J; Paradis, Valérie; Francque, Sven M
细胞生物学
内皮细胞
发表日期：2025
文献求助 收藏

The pan-PPAR agonist lanifibranor improves cardiometabolic health in patients with metabolic dysfunction-associated steatohepatitis

泛PPAR激动剂lanifibranor可改善代谢功能障碍相关脂肪性肝炎患者的心血管代谢健康

期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-024-47919-9
Cooreman, Michael P; Butler, Javed; Giugliano, Robert P; Zannad, Faiez; Dzen, Lucile; Huot-Marchand, Philippe; Baudin, Martine; Beard, Daniel R; Junien, Jean-Louis; Broqua, Pierre; Abdelmalek, Manal F; Francque, Sven M
肝炎
代谢
发表日期：2024
文献求助 收藏

Biomarkers of Glycosaminoglycans (GAG) accumulation in patients with mucopolysaccharidosis type VI-LeukoGAG, Corneal Opacification (COM) and Carotid Intima Media Thickening (CIMT)

粘多糖贮积症 VI 型患者糖胺聚糖 (GAG) 积累的生物标志物：白细胞糖胺聚糖 (LeukoGAG)、角膜混浊 (COM) 和颈动脉内膜中层增厚 (CIMT)

期刊:Molecular Genetics and Metabolism Reports
影响因子:1.9
doi:10.1016/j.ymgmr.2023.101041
Sohn, Young Bae; Wang, Raymond; Ashworth, Jane; Broqua, Pierre; Tallandier, Mireille; Abitbol, Jean-Louis; Jozwiak, Erin; Pollard, Laura; Wood, Timothy C; Aslam, Tariq; Harmatz, Paul R
细胞生物学
发表日期：2024
文献求助 收藏

Reduction of lysosome abundance and GAG accumulation after odiparcil treatment in MPS I and MPS VI models

在 MPS I 和 MPS VI 模型中，odiparcil 治疗后溶酶体丰度和 GAG 积累减少

期刊:Molecular Genetics and Metabolism Reports
影响因子:1.8
doi:10.1016/j.ymgmr.2023.101011
Pascale Tuyaa-Boustugue, Ingrid Jantzen, Haoyue Zhang, Sarah P Young, Pierre Broqua, Mireille Tallandier, Eugeni Entchev
信号转导
发表日期：2023
文献求助 收藏

CD8+T cell responsiveness to anti-PD-1 is epigenetically regulated by Suv39h1 in melanomas

在黑色素瘤中，CD8+T 细胞对抗 PD-1 的反应受 Suv39h1 的表观遗传调控

期刊:Nature Communications
影响因子:14.7
doi:10.1038/s41467-022-31504-z
Leticia Laura Niborski, Paul Gueguen, Mengliang Ye, Allan Thiolat, Rodrigo Nalio Ramos, Pamela Caudana, Jordan Denizeau, Ludovic Colombeau, Raphaël Rodriguez, Christel Goudot, Jean-Michel Luccarini, Anne Soudé, Bruno Bournique, Pierre Broqua, Luigia Pace, Sylvain Baulande, Christine Sedlik, Jean-Pie
肿瘤
黑色素瘤
T细胞
发表日期：2022
文献求助 收藏

The pan-PPAR agonist lanifibranor reduces development of lung fibrosis and attenuates cardiorespiratory manifestations in a transgenic mouse model of systemic sclerosis

泛PPAR激动剂lanifibranor可减少系统性硬化症转基因小鼠模型中的肺纤维化发展并减轻心肺症状。

期刊:Arthritis Research & Therapy
影响因子:4.6
doi:10.1186/s13075-021-02592-x
Derrett-Smith, Emma; Clark, Kristina E N; Shiwen, Xu; Abraham, David J; Hoyles, Rachel K; Lacombe, Olivier; Broqua, Pierre; Junien, Jean Louis; Konstantinova, Irena; Ong, Voon H; Denton, Christopher P
系统性硬化症
免疫/内分泌
发表日期：2021
文献求助 收藏

Odiparcil, a potential glycosaminoglycans clearance therapy in mucopolysaccharidosis VI-Evidence from in vitro and in vivo models

Odiparcil，一种治疗粘多糖贮积症的潜在糖胺聚糖清除疗法 VI-来自体外和体内模型的证据

期刊:PLoS One
影响因子:2.9
doi:10.1371/journal.pone.0233032
Eugeni Entchev, Ingrid Jantzen, Philippe Masson, Stephanie Bocart, Bruno Bournique, Jean-Michel Luccarini, Andre Bouchot, Olivier Lacombe, Jean-Louis Junien, Pierre Broqua, Mireille Tallandier
信号转导
发表日期：2020
文献求助 收藏

Parafoveal-on-foveal repetition effects in sentence reading: A co-registered eye-tracking and electroencephalogram study

句子阅读中中心凹旁重复效应：一项同步眼动追踪和脑电图研究

期刊:Psychophysiology
影响因子:2.8
doi:10.1111/psyp.13553
Mirault, Jonathan; Yeaton, Jeremy; Broqua, Fanny; Dufau, Stéphane; Holcomb, Phillip J; Grainger, Jonathan
神经科学
发表日期：2020
文献求助 收藏

The new-generation pan-peroxisome proliferator-activated receptor agonist IVA337 protects the liver from metabolic disorders and fibrosis

新一代泛过氧化物酶体增殖物激活受体激动剂IVA337可保护肝脏免受代谢紊乱和纤维化的影响。

期刊:Hepatology Communications
影响因子:4.6
doi:10.1002/hep4.1057
Wettstein, Guillaume; Luccarini, Jean-Michel; Poekes, Laurence; Faye, Patrick; Kupkowski, Francine; Adarbes, Vanessa; Defrêne, Evelyne; Estivalet, Céline; Gawronski, Xavier; Jantzen, Ingrid; Philippot, Alain; Tessier, Julien; Tuyaa-Boustugue, Pascale; Oakley, Fiona; Mann, Derek A; Leclercq, Isabelle; Francque, Sven; Konstantinova, Irena; Broqua, Pierre; Junien, Jean-Louis
信号转导
代谢
发表日期：2017
文献求助 收藏

Pan PPAR agonist IVA337 is effective in prevention and treatment of experimental skin fibrosis

泛PPAR激动剂IVA337可有效预防和治疗实验性皮肤纤维化

期刊:Annals of the Rheumatic Diseases
影响因子:20.6
doi:10.1136/annrheumdis-2015-208029
Ruzehaji, Nadira; Frantz, Camelia; Ponsoye, Matthieu; Avouac, Jerome; Pezet, Sonia; Guilbert, Thomas; Luccarini, Jean-Michel; Broqua, Pierre; Junien, Jean-Louis; Allanore, Yannick
发表日期：2016
文献求助 收藏